ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
ARTV
53 hedge funds and large institutions have $62.8M invested in Artiva Biotherapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
4
Increased
22
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$597K |
2 |
Geode Capital Management
Boston,
Massachusetts
|
+$284K |
3 |
Citadel Advisors
Miami,
Florida
|
+$124K |
4 |
SEI Investments
Oaks,
Pennsylvania
|
+$87.8K |
5 |
Northern Trust
Chicago,
Illinois
|
+$73.7K |